The Enterprise Value as of March 2026 (TTM) for Aquestive Therapeutics, Inc. (AQST) is 405.52M

According to Aquestive Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 405.52M. This represents a change of -17.75% compared to the average of 493.02M of the last 4 quarters.

Aquestive Therapeutics, Inc. (AQST) Historical Enterprise Value (quarterly & annually)

How has AQST Enterprise Value performed in the past?

The mean historical Enterprise Value of Aquestive Therapeutics, Inc. over the last ten years is 269.35M. The current 405.52M Enterprise Value has changed 14.96% with respect to the historical average. Over the past ten years (40 quarters), AQST's Enterprise Value was at its highest in in the December 2025 quarter at 798.18M. The Enterprise Value was at its lowest in in the June 2017 quarter at 0.

Aquestive Therapeutics, Inc. (AQST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aquestive Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aquestive Therapeutics, Inc. (AQST) Average Enterprise Value

How has AQST Enterprise Value performed in the past?

The current Enterprise Value of Aquestive Therapeutics, Inc. (AQST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Aquestive Therapeutics, Inc. (AQST) Enterprise Value vs. Peers

How is AQST’s Enterprise Value compared to its peers?

Aquestive Therapeutics, Inc.’s Enterprise Value is less than Esperion Therapeutics, Inc. (910.32M), greater than SNDL Inc. (377.65M), greater than SIGA Technologies, Inc. (-154966059281495.00), less than Emergent BioSolutions Inc. (796.84M), less than MoonLake Immunotherapeutics (908.20M), greater than Anavex Life Sciences Corp. (244.50M), less than Orthofix Medical Inc. (614.92M), less than Erasca, Inc. (4.51B), greater than DarioHealth Corp. (59.50M), less than Arvinas, Inc. (568.21M),

Build a custom stock screener for Aquestive Therapeutics, Inc. (AQST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aquestive Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aquestive Therapeutics, Inc. (AQST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aquestive Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.